Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Counsyl | RCV000665011 | SCV000789064 | uncertain significance | Usher syndrome type 2A; Retinitis pigmentosa 39 | 2017-01-19 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000924302 | SCV001069813 | likely benign | not provided | 2024-01-31 | criteria provided, single submitter | clinical testing | |
Blueprint Genetics | RCV001073347 | SCV001238887 | uncertain significance | Retinal dystrophy | 2018-12-13 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000924302 | SCV001840912 | likely benign | not provided | 2020-11-30 | criteria provided, single submitter | clinical testing | This variant is associated with the following publications: (PMID: 31054281, 30703234, 24938718) |
Dept Of Ophthalmology, |
RCV001073347 | SCV004707256 | likely benign | Retinal dystrophy | 2023-10-01 | criteria provided, single submitter | research | |
Natera, |
RCV001835069 | SCV002088290 | likely benign | Usher syndrome type 2A | 2020-08-10 | no assertion criteria provided | clinical testing | |
Prevention |
RCV004533463 | SCV004741510 | likely benign | USH2A-related disorder | 2022-12-23 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |